OUR BIO

Meet the Leadership Behind
InjuryPro Capital

Our leadership team is composed of professionals with extensive experience across medical receivables, fund operations, financial management, and compliance. Together, they ensure InjuryPro Capital operates with discipline, transparency, and long-term vision

Experienced
Leadership

Healthcare
Expertise

Governance
Focused

To make the vision a reality, our Founder brought together a team of seasoned professionals with deep roots in finance, operations, underwriting, and law

JAMES BRADFORD

JAMES BRADFORD

Chief Executive Officer (CEO)

Jim Bradford is the Founder of
Injury Pro Management Fund X LLC
and has served in various founder/leadership roles at several prominent medical receivables companies, where he has deployed $460M+ to manage over $1.6 B+ in medical receivable assets. With over 20 years of leadership across healthcare receivables, financial services, and technology, Jim has a proven record of scaling businesses through disciplined sourcing, underwriting, and portfolio management. At Injury Pro Management Fund X LLC, he is leveraging this track record to deliver innovative funding solutions that read more...

CODY SHANDRAW

CODY SHANDRAW

President (P)

Cody Shandraw is a seasoned entrepreneur, investor and finance executive with a proven record over 15 years of building mission-driven platforms at the intersection of finance, healthcare and capital markets. As Co-Founder and President of Injury Pro Capital, Cody co-heads the InjuryPro family of companies — InjuryPro Capital, the investor division connecting private capital with a collateralized medical receivables asset class; InjuryPro Management, which provides medical providers with timely receivables financing and cash flow support; and the InjuryPro Management Funds, the Company's read more...

ZED WANG

ZED WANG

Chief Financial Officer (CFO)

As Chief Financial Officer, Zed is responsible for building the financial operating infrastructure planning, reporting, controls, and investor communications-that allows the company to scale efficiently and transparently. He translates the CEO's strategy into actionable financial roadmaps, partners with the President and COO to align operating plans with capital needs, and oversees fund administration, treasury, underwriting-to-collections finance workflows, reporting and tax processes. Zed also leads investor reporting and portfolio analytics, implementing data-driven systems to safeguard read more...

AARON RAUB

AARON RAUB

Chief Operating Officer (COO)

As Chief Operating Officer, Aaron is responsible for building the operational infrastructure-systems, processes, and tools-that enable the company to scale rapidly and efficiently. He specializes in translating the CEO's vision and fundraising strategy into actionable operating plans that align resources with growth objectives. In addition, Aaron partners closely with the CEO and CFO on capital-raising initiatives, assisting in operational planning, creating investor materials, and performing due diligence to ensure organizational readiness with a fiduciary perspective. Aaron is a seasoned read more...

PEYTON PIPES

PEYTON PIPES

Chief Legal Officer (CLO)

Chief Legal Officer (CLO) As Chief Legal Officer, Peyton is responsible for ensuring that risk is minimized and that all regulatory requirements are met. Peyton ensures that operations are compliant with various state frameworks and federal law along with overseeing standard corporate governance procedures for the Company. Peyton is responsible for developing and implementing due diligence policies and procedures used to ensure that receivables will ultimately be collected in an efficient and timely manner. Prior to joining the team, Peyton has served as Managing Partner of Koon & Pipes read more...

Together, our team blends financial sophistication, technological innovation, and deep industry insight to create a better way forward in healthcare finance

Investor Materials

If you are interested in learning how to participate, you can review our investor materials here.

Schedule A Call

Speak directly with our Investor Relations team to discuss your goals and review current opportunities